Month of birth is not a definite risk factor for multiple sclerosis
Sá, M.José.
Arquivos de Neuro-Psiquiatria 72(5): 397
2014
ISSN/ISBN: 0004-282X PMID: 24863521 Document Number: 677083
Document emailed within 1 workday
Related Documents
Farooq, L.; Le, K.; Palacios, E.; Neitzschman, H.R. 2011: Radiology case of the month. Tumefactive multiple sclerosis Journal of the Louisiana State Medical Society: official organ of the Louisiana State Medical Society 163(1): 19-201990: Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group JAMA 263(13): 1795-1801
Radnai, Márta.; Gorzó, Ián. 2002: Periodontal disease as a potential risk factor for preterm birth and low birth weight (Literature review) Fogorvosi Szemle 95(6): 241-244
Kostecki, J.; Zaniewski, M.; Ziaja, K.; Urbanek, T.; Kuczmik, W.; Krzystanek, E.; Ziaja, D.; Korzeniowski, T.; Majewski, E.; Hartel, M.; Swiat, M.; Sioma-Markowska, U. 2011: An endovascular treatment of Chronic Cerebro-Spinal Venous Insufficiency in multiple sclerosis patients - 6 month follow-up results Neuro Endocrinology Letters 32(4): 557-562
Rumbach, L.; Dietemann, J.L.; Tranchant, C.; Bodiguel, E.; Warter, J.M.; Collard, M. 1990: Magnetic resonance imaging after a one-month interval of lesions of multiple sclerosis in 2 populations, one during an acute attack treated with methylprednisolone, the other stable with no treatment Revue Neurologique (Paris) 146(6-7): 430-433
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Drăgănescu, N. 1987: Multiple sclerosis. Risk factors Virologie 38(3): 223-234
Magdzik, W.ła.; Zieliński, A. 2005: Vaccination against hepatitis B and the risk of multiple sclerosis Przeglad Epidemiologiczny 59(1): 11-19
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Alatab, S.; Maghbooli, Z.; Hossein-Nezhad, A.; Khosrofar, M.; Mokhtari, F. 2011: Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes Minerva Medica 102(6): 461-468
Mapelli, G.; De Palma, P.; Sebastiani, A.; Fini, M.; Franco, F. 1986: Risk of multiple sclerosis in optic neuritis. A prospective study Acta Neurologica 8(6): 619-625
Gusev, E.I.; Boĭko, A.N.; Smirnova, N.F.; Demina, T.L. 1999: Risk factors of multiple sclerosis in Moscow population. I. Exogenous risk factors Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 99(5): 32-40
Alonso, A.; Clark, C.J. 2009: Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence Journal of the Neurological Sciences 286(1-2): 73-75
Maricq, H.R.; Diat, F.; Weinrich, M.C.; Maricq, J.G. 1994: Digital pressure responses to cooling in patients with suspected early vs definite scleroderma (systemic sclerosis) vs primary Raynaud's phenomenon Journal of Rheumatology 21(8): 1472-1476
Raine, C.S.; Bonetti, B.; Cannella, B. 1998: Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque Revue Neurologique (Paris) 154(8-9): 577-585
Mustafina, O.E.; Mikhaĭlova, A.M.; Bakhtiiarova, K.Z.; Nasibulin, T.R.; Tuktarova, I.A.; Makarycheva, O.I.; Sudomoina, M.A.; Boĭko, A.N.; Voronchikhina, S.A.; Volkova, L.I.; Magzhanov, R.V.; Favorova, O.O. 2008: Polymorphism of APOE gene and risk of development of the multiple sclerosis at ethnic Russians Molekuliarnaia Biologiia 42(6): 957-964
Brancati, F.L.; Whelton, P.K.; Randall, B.L.; Neaton, J.D.; Stamler, J.; Klag, M.J. 1997: Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial JAMA 278(23): 2069-2074